Scot Harper
Chief Tech/Sci/R&D Officer bei RADIOPHARM THERANOSTICS LIMITED
Profil
Scot L.
Harper is currently the Senior Vice President-Clinical Operations at Radiopharm Theranostics Ltd.
Previously, he worked as the Vice President-Clinical Operations at Endocyte, Inc. from 2013 to 2016.
Harper received his undergraduate degree from DePauw University, his graduate degree from the University of South Alabama, and his doctorate from The Indiana University School of Medicine.
Aktive Positionen von Scot Harper
| Unternehmen | Position | Beginn |
|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Chief Tech/Sci/R&D Officer | 01.12.2021 |
Ehemalige bekannte Positionen von Scot Harper
| Unternehmen | Position | Ende |
|---|---|---|
| ENDOCYTE, INC. | Chief Tech/Sci/R&D Officer | 28.10.2016 |
Ausbildung von Scot Harper
| DePauw University | Undergraduate Degree |
| University of South Alabama | Graduate Degree |
| The Indiana University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Health Services |
| Private Unternehmen | 1 |
|---|---|
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
